NK-cell enteropathy: A benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: Clinicopathologic features and follow-up in a unique case series

Blood

Volumn 117, Issue 5, 2011, Pages 1447-1452

  Mansoor, Adnan ^a   Pittaluga, Stefania ^b   Beck, Paul L ^c   Wilson, Wyndham H ^b   Ferry, Judith A ^d   Jaffe, Elaine S ^b  

^a CALGARY LABORATORY SERVICES   (Canada)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANZYME B; PREDNISONE; RNA; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR GAMMA; UNCLASSIFIED DRUG; VINCRISTINE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; COLON CANCER; COLONOSCOPY; CONSTIPATION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DIVERTICULOSIS; EDEMA; ENDOSCOPIC BIOPSY; ENTEROPATHY; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; INTESTINE EPITHELIUM; INTESTINE LYMPHOMA; MALE; NATURAL KILLER CELL; NATURAL KILLER CELL ENTEROPATHY; NK T CELL LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; STOMACH HEMORRHAGE; STOMACH ULCER;

EID: 79551616391     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-08-302737     Document Type: Article

References (39)

1. Chan JKC, Quintanilla-Martinez L, Ferry JA, Peh SC. Extranodal NK-/T-cell lymphoma, nasal type. In: Swerdlow S, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer Press; 2008:285-288.
2. Meijer JW, Mulder CJ, Goerres MG, Boot H, Schweizer JJ. Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment. Scand J Gastroenterol Suppl. 2004;241:78-84. (Pubitemid 40051455)
3. van de Water JM, Cillessen SA, Visser OJ, Verbeek WH, Meijer CJ, Mulder CJ. Enteropathy associated T-cell lymphoma and its precursor lesions. Best Pract Res Clin Gastroenterol. 2010;24(1):43-56.
4. Kwong YL, Chan AC, Liang R, et al. CD56+ NK lymphomas: clinicopathological features and prognosis. Br J Haematol. 1997;97(4):821-829. (Pubitemid 27321382)
5. Au WY,Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood. 2009;113(17):3931-3937.
6. Jaffe ES. Pathobiology of peripheral T-cell lymphomas. Hematology Am Soc Hematol Educ Program. 2006:317-322.
7. Bagdi E, Diss TC, Munson P, Isaacson PG. Mucosal intra-epithelial lymphocytes in enteropathyassociated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood. 1999;94(1):260-264. (Pubitemid 29300157)
8. Chott A, HaedickeW, Mosberger I, et al. Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol. 1998;153(5):1483-1490.
9. Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol. 2000;18(4):795-803. (Pubitemid 30106610)
10. Arnulf B, Copie-Bergman C, Delfau-Larue MH, et al. Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood. 1998;91(5):1723-1731.
11. Egawa N, Fukayama M, Kawaguchi K, et al. Relapsing oral and colonic ulcers with monoclonal T-cell infiltration: a low grade mucosal T-lymphoproliferative disease of the digestive tract. Cancer. 1995;75(7):1728-1733.
12. Ranheim EA, Jones C, Zehnder JL, Warnke R, Yuen A. Spontaneously relapsing clonal, mucosal cytotoxic T-cell lymphoproliferative disorder: case report and review of the literature. Am J Surg Pathol. 2000;24(2):296-301. (Pubitemid 30078720)
13. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187-376.
14. Tagliabue A, Befus AD, Clark DA, Bienenstock J. Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria. J Exp Med. 1982;155(6):1785-1796. (Pubitemid 12074215)
15. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9(5):503-510.
16. Parolini S, Santoro A, Marcenaro E, et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood. 2007;109(9):3625-3632.
17. Ng SB, Lai KW, Murugaya S, et al. Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol. 2004;17(9):1097-1107. (Pubitemid 39128236)
18. Vega F, Chang CC, Schwartz MR, et al. Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease. Am J Surg Pathol. 2006;30(4):539-544. (Pubitemid 43740158)
19. Krenacs L, Smyth MJ, Bagdi E, et al. The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity. Blood. 2003;101(9):3590-3593. (Pubitemid 36857946)
20. Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer: a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010;34(3):405-417.
21. Morice WG, Kurtin PJ, Leibson PJ, Tefferi A, Hanson CA. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Haematol. 2003;120(6):1026-1036. (Pubitemid 36411562)
22. McCarthy KP, Sloane JP, Kabarowski JH, Matutes E, Wiedemann LM. A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene. Diagn Mol Pathol. 1992;1(3):173-179.
23. Trainor KJ, Brisco MJ,Wan JH, Neoh S, Grist S, Morley AA. Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood. 1991;78(1):192-196.
24. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer Press; 2008.
25. Isaacson PG, Chott A, Ott G, Stein H. Enteropathy-associated T-cell lymphoma. In: Swerdlow S, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer Press; 2008:289-291.
26. Deleeuw RJ, Zettl A, Klinker E, et al. Wholegenome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology. 2007;1902-1911.
27. Meresse B, Curran SA, Ciszewski C, et al. Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med. 2006;203(5):1343-1355.
28. Jabri B, Kasarda DD, Green PH. Innate and adaptive immunity: the yin and yang of celiac disease. Immunol Rev. 2005;206:219-231. (Pubitemid 41105173)
29. Isaacson PG. Relation between cryptic intestinal lymphoma and refractory sprue. Lancet. 2000;356(9225):178-179.
30. Roullet MR, Cornfield DB. Large natural killer cell lymphoma arising from an indolent natural killer cell large granular lymphocyte proliferation. Arch Pathol Lab Med. 2006;130(11):1712-1714.
31. Huang Q, Chang KL, Gaal KK, Weiss LM. An aggressive extranodal NK-cell lymphoma arising from indolent NK-cell lymphoproliferative disorder. Am J Surg Pathol. 2005;29(11):1540-1543. (Pubitemid 41513307)
32. Long EO. Ready for prime time: NK cell priming by dendritic cells. Immunity. 2007;26(4):385-387.
33. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol. 2006;7(5):507-516.
34. Lambiase A, Normando EM, Vitiello L, et al. Natural killer cells in vernal keratoconjunctivitis. Mol Vis. 2007;13:1562-1567. (Pubitemid 47354371)
35. Buentke E, Heffler LC, Wilson JL, et al. Natural killer and dendritic cell contact in lesional atopic dermatitis skin: Malassezia-influenced cell interaction. J Invest Dermatol. 2002;119(4):850-857. (Pubitemid 35340910)
36. Ottaviani C, Nasorri F, Bedini C, de Pita O, Girolomoni G, Cavani A. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol. 2006;36(1):118-128. (Pubitemid 43116398)
37. Takeuchi K, Yokoyama M, Ishizawa S, et al. Lymphomatoid gastropathy: a distinct clinicopathological entity of self-limited pseudomalignant NK-cell proliferation. Blood. 2010;116(25):5631-5637.
38. Middendorp S, Nieuwenhuis EE. NKT cells in mucosal immunity. Mucosal Immunol. 2009;2(5):393-402.
39. Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family. Nat Immunol. 2010;11(3):197-206.